SII invests in IntegriMedical to advance India’s 1st needle-free tech

Pune, May 17 (IANS) Serum Institute of India (SII), the world’s largest vaccine manufacturer, on Friday announced a strategic investment in IntegriMedical to advance Needle-Free Injection System (N-FIS) technology.

 

With the investment, SII will acquire a 20 per cent stake in IntegriMedical. The investment will also accelerate the development and commercialisation of the N-FIS technology, making it more widely accessible to patients in India and worldwide“At SII, we are constantly seeking opportunities to invest in technologies that align with our mission to make healthcare accessible and affordable for people worldwide.

 

Read more@ https://hiindia.com/sii-invests-in-integrimedical-to-advance-indias-1st-needle-free-tech-20240517103607-11/

Comments

Popular posts from this blog

Intramuscular Injections

Intramuscular Injections: The Future of Pain-Free Vaccinations

Subcutaneous Injections